本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Castle Biosciences, Inc.

18.54
-0.7300-3.79%
成交量:58.16萬
成交額:1,076.00萬
市值:5.35億
市盈率:-100.50
高:19.36
開:19.12
低:18.08
收:19.27
資料載入中...
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities